Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Clinical, toxicological, and pathological aspects of arsanilic acid poisoning in swine

Journal Article · · Clin. Toxicol.; (United States)

In Trial I, toxicosis was induced in 27 pigs by feeding 1000 ppM arsanilic acid in the ration. The clinical syndrome was first characterized by transient diarrhea and incoordination, with posterior paresis and quadriplegia later. Detectable histopathological changes were confined to the optic tracts, optic nerves, and peripheral nerves. Major lesions noted were necrosis of myelin-supporting cells and degeneration of myelin sheaths and axons. Maximum mean arsenic levels were present in liver, kidney, skeletal muscle, rib, and blood on or before day 13 of the experiment. Maximum mean arsenic levels in the nervous system were not attained until days 19 and 21. In Trial II, six pigs were fed 1000 ppM arsanilic acid in the ration for 19 days. Three days after the removal of dietary arsanilic acid, skeletal muscle, kidney, liver, and blood, respectively, retained 31, 34, 32, and 13 mean % of the tissue arsenic present at the time of drug withdrawal. Nervous tissue retained 100, 93, 57 mean % arsenic 3, 6, and 11 days post-withdrawal, respectively. In Trial III, six pigs were fed 1000 ppM arsanilic acid in the ration until they developed severe posterior paresis or quadriplegia. Four pigs had no clinical improvement and two pigs developed a more severe paralysis after withdrawal of the drug. 12 references, 10 figures, 5 tables.

Research Organization:
Iowa State Univ., Ames
OSTI ID:
6863250
Journal Information:
Clin. Toxicol.; (United States), Journal Name: Clin. Toxicol.; (United States) Vol. 6:3; ISSN CTOXA
Country of Publication:
United States
Language:
English